Melissa Fields đã retweet

Fascinating, and great job by all - 2 large trials that answer an important question.
Glad that we reserved a decision on a broader rollout of IO in our service (from just CCPs to all paramedics) while awaiting the results of PARAMEDIC3.
#researchmatters
Tommaso Scquizzato, MD@tscquizzato
2 RCTs testing IV vs IO vascular access in OHCA patients just published in the @NEJM and concomitantly presented at #RESUS24 @ERC_resus ➡️ No difference in 30d survival in both trials ➡️ Higher rate of ROSC with IV access in the #PARAMEDIC3 trial 🇬🇧 nejm.org/doi/full/10.10… 🇩🇰 nejm.org/doi/full/10.10… Congratulations to the authors for randomizing 6082 + 1506 patients to answer this important question!
English


















